Eli Lilly in deal to supply Covid-19 drugs to low-income countries
Gilead 2020: HIV … and COVID?
AstraZeneca 2020: Driven by Covid-19
Eli Lilly Files For FDA Emergency Use Of COVID-19 Antibody Treatment
Pfizer 2020: Cancer and COVID-19
Roche 2020: Built for innovation
Is Quidel a Good Coronavirus Stock to Buy? Analyst Weighs In
Nobel Prize for chemistry honors exquisitely precise gene-editing technique, CRISPR – a gene engineer explains how it works
White House Reverses Course, Approves New FDA COVID-19 Vaccine Guidelines
Eli Lilly to seek U.S. emergency use for Covid-19 treatment
White House Acquiesces To FDA's COVID-19 Vaccine Emergency-Approval Guidelines
FDA Outlines Requirements For "Emergency Use Authorization" Of COVID-19 Vaccine Amid Reports Of WH Interference
The 6 Degrees of Separating Coronavirus from President Trump
Gilead vs Pfizer: Which Healthcare Stock Has Stronger Prospects?
Trump’s Treatments: Regeneron’s Antibodies and Gilead’s Remdesivir Explained
Regeneron: Initial Data From REGN-COV2 Trial Shows Promise, but Capacity Remains an Issue
Trump treated with experimental antibody cocktail for Covid-19
Alone in the spotlight, Pfizer CEO Bourla swears pure intentions in the rush to develop a Covid-19 vaccine. But will the public believe it?
Moderna says Covid-19 vaccine unlikely to be ready before U.S. election – FT
Eli Lilly to continue other Covid-19 antibody drug trials after pausing one on safety concerns
BD’s 15-Minute Covid-19 Test Wins EU Clearance; Shares Rise 3.7%
Regeneron Up 4% As Covid-19 Cocktail Lowers Viral Levels; Analyst Says Hold
Despite COVID-19 Vaccine Trial Delay, AstraZeneca Is Still a Buy, Says Analyst
Analyst: Don’t Say Buy Buy to Moderna Stock, Say Bye Bye
White House Could Attempt to Overrule Potential New FDA Vaccine Guidance
Luminex Wins US Award For Covid-19 Antibody Test Project
Exclusive: Top adviser steps aside from FDA Covid-19 vaccine reviews over potential conflict
FDA’s New Moves Can’t Allay Coronavirus Vaccine Fears
J&J’s One-Dose COVID-19 Vaccine Candidate Begins Phase III Trial
J&J Kicks Off Phase 3 Covid-19 Vaccine Trial With Single Dose